Effects of preeclamptic plasma on potassium currents of human umbilical vein endothelial cells

Reproductive Sciences

Volumn 19, Issue 4, 2012, Pages 391-399

  Watanapa, Wattana B ^a   Theerathananon, Wuttinan ^a   Akarasereenont, Pravit ^a   Techatraisak, Kitirat ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

calcium sensitive potassium channels; hypertensive disorder of pregnancy; inward rectifier potassium channel

Indexed keywords

ANTIHYPERTENSIVE AGENT; APAMIN; CALCIUM SENSITIVE POTASSIUM CHANNEL; G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL; IBERIOTOXIN; MAGNESIUM SULFATE; POTASSIUM CHANNEL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; PATCH CLAMP; POTASSIUM CURRENT; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; UMBILICAL VEIN ENDOTHELIAL CELL;

ADULT; APAMIN; FEMALE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFANT, NEWBORN; PATCH-CLAMP TECHNIQUES; PEPTIDES; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; POTASSIUM CHANNELS, INWARDLY RECTIFYING; PRE-ECLAMPSIA; PREGNANCY; STATISTICS, NONPARAMETRIC;

EID: 84859892966     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719111424434     Document Type: Article

References (51)

1. World Health Organization International Collaborative Study of Hypertensive Disorder of Pregnancy. Geographic variation in the incidence of hypertension. Am J Obstet Gynecol. 1998;158(1):80-83.
2. ACOG. Diagnosis and management of preclampsia and eclampsia. ACOG Pract Bull. 2002;33(1):1-14.
3. World Health Organization. World Health Report: Make Every Mother, and Child Count. Geneva: World Health Org., 2005.
4. VanWijk MJ, Kublickiene K, Boer K, VanBavel E. Vascular function in preeclampsia. Cardiovasc Res. 2000;47(1):38-48. (Pubitemid 30408548)
5. Noris M, Perico N, Remuzzi G. Mechanisms of disease: preeclampsia. Nat Clin Pract Nephrol. 2005;1(2):98-114.
6. Wang A, Rana S, Karumanchi SA. Preeclampsia: the role of angiogenic factors in its pathogenesis. Physiology. 2009;24(3):147-158.
7. Khalil RA, Crews JK, Novax L, Kassab S, Granger JP. Enhanced vascular activity during inhibition of nitric oxide synthesis in pregnant rats. Hypertension. 1998;31(5):1065-1069. (Pubitemid 28191498)
8. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol. 1989;161(5):1200-1204. (Pubitemid 20007682)
9. Wang J, Trudinger B. Endothelial cell dysfunction in preeclampsia. J Nephrol. 1998;11(2):53-56.
10. Gilbert JS, Ryan MJ, LaMarca BB, Sedeek M, Murpht SR, Granger JP. Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am J Physiol Heart Circ Physiol. 2008;294(2):H541-H550. (Pubitemid 351253261)
11. Myatt L,Webster RP. Vascular biology of preeclampsia. J Thromb Heamatost. 2009;7(3):375-384.
12. Chambers JC, Fusi L, Malik IS, Haskard DO, De Swiet M, Kooner JS. Association of maternal endothelial dysfunction with preeclampsia. JAMA. 2001;285(12):1607-1612. (Pubitemid 32240253)
13. Germain JM, Romanik MC, Guerra I, et al. Endothelial dysfunction: a link among preeclampsia, recurrent pregnancy loss, and future cardiovascular events? Hypertens. 2007;49(1):90-95. (Pubitemid 46360346)
14. Agatisa PK, Ness RB, Roberts JM, Costantino JP, Kuller LH, Mclaughlin MK. Impairment of endothelial function in women with a history of preeclampsia: an indicator of cardiovascular risk. Am J Physiol Heart Circ Physiol. 2004;286(4):H1389-H1393. (Pubitemid 38381146)
15. Baker PN, Davidge ST, Barankiewic ZJ, Roberts JM. Plasma of preeclamptic women stimulates and then inhibits endothelial prostacyclin. Hypertension. 1996;27(1):56-61. (Pubitemid 26017681)
16. Pinto A, Sorrentino R, Sorrentino P, et al. Endothelial-derived relaxing factor released by endothelial cells of human umbilical vessels and its impairment in pregnancy-induced hypertension. Am J Obstet Gynecol. 1991;164(2):507-513.
17. Rodgers GM, Taylor RN, Roberts JM. Preeclampsia is associated with a serum factor cytotoxic to human endothelial cell. Am J Obstet Gynecol. 1998;159(4):908-914.
18. Scalera F, Schlembach D, Beinder E. Production of vasoactive substances by human umbilical vein endothelial cells after incubation with serum from preeclamptic patients. Eur J Obstet Gynecol Reprod Biol. 2001;99(2):172-178. (Pubitemid 34098741)
19. Smarason AK, Sargent IL, Redman CW. Endothelial cell proliferation is suppressed by plasma but not serum from women with preeclampsia. Am J Obstet Gynecol. 1996;174(2):787-793. (Pubitemid 26070180)
20. Tsukimori K, Maeda H, Shingu M, Koyanagi T, Nobunaga M, Nakano H. Possible mechanism of vascular damage in preeclampsia. J Human Hypertens.1994;8(3):177-180. (Pubitemid 24090273)
21. Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111(5):649-658.
22. Nilius B, Droogmans G. Ion channels and their functional role in vascular endothelium Physiol Rev. 2001;81(4):1415-1459. (Pubitemid 32947776)
23. Kamouchi M, Mamin A, Droogmans G, Nilius B. Nonselective cation channels in endothelial cells derived from human umbilical vein. J Membr Biol. 1999;169(1):29-38. (Pubitemid 29211071)
24. Nilius B, Schwartz G, Oike M, Droogmans G. Histamineactivated, non-selective cation currents and Ca2+ transients in endothelial cells from human umbilical vein. Pflugers Arch. 1993;424(3-4):285-293. (Pubitemid 23227683)
25. Steinert JR, Wyatt AW, Poston L, Jacob R, Mann GE. Preeclampsia is associated with altered Ca2+ regulation and NO production in human fetal venous endothelial cells. FASEB J. 2002;16(7):721-723.
26. Köhler R, Schönfelder G, Hopp H, Distler A, Hoyer J. Stretchactivated cation channel in human umbilical vein endothelium in normal pregnancy and in preeclampsia. J Hypertens. 1998;16(8):1149-1156. (Pubitemid 28334017)
27. ++oscillation in endothelial cell and preclampsia. Lancet. 1998;351(9114):1490-1491.
28. Akarasereenont P. Regulation and Pharmacology of the Inducible Cyclooxygenase (COX-2) [Ph.D. Thesis in Pharmacology]. London, UK: University of London; 1995.
29. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins, identification by morphologic and immunologic criteria. J Clin Invest. 1973;52(11):2745-2756.
30. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 1981;391(2):85-100. (Pubitemid 11012976)
31. Jacobs ER, Cheliakine C, Gebremedhin D, Birks EK, Davies PF, Harder DR. Shear activated channels in cell-attached patches of cultured bovine aortic endothelial cells. Pflugers Arch. 1995;431(1):129-131.
32. Kamouchi M, Vandenbremt K, Eegermont J, Droogmans G, Nilius B. Modulation of inwardly rectifying potassium channels in cultured bovine pulmonary artery endothelial cells. J Physiol (Lond). 1997;507(pt 3):545-556. (Pubitemid 27493854)
33. Himmel HM, Rauen U, Ravens U. Microvascular endothelial cells from human omentum lack an inward rectifier K+ current. Physiol Res. 2001;50(6):547-555. (Pubitemid 34087273)
34. Watanapa WB, Chanwongse K, Akarasereenont P, Techatrisak K. Comparison of endothelial K channels in preeclampsia and normal pregnancy. Siriraj Hosp Gaz. 2003;55(suppl 1):173-174.
35. Chiang HT, Wu SN. Inhibition of large-conductance calcium-activated potassium channels by 2-methoxyestradiol in cultured vascular endothelial (HUV-EC-C) cells. J Membr Biol. 2001;182(3):203-212.
36. Wu SN, Jan CR, Li HF, Chen SA. Stimulation of large-conductance calcium-activated potassium channels by Evan Blue in cultured endothelial cells of human umbilical vein. Biochem Biophysic Res Comm. 1999;254(3):666-674.
37. Zhang H, Inazu M, Weir B, Daniel E. Endothelin-1 inhibits inward rectifier potassium channels and activates nonspecific cation channels in cultured endothelial cells. Pharmacology. 1994;49(1):11-22. (Pubitemid 24161024)
38. Bychkov R, Pieper K, Ried C, et al. Hydrogen peroxide, potassium currents, and membrane potential in human endothelial cells. Circulation. 1999;99(13):1719-1725. (Pubitemid 29162485)
39. + channels by oxidized LDL and its contribution to endothelial proliferation. Cardiovasc Res. 2003;60(3):626-634.
40. Ahmad S, Ahmed A. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ Res. 2004;95(9):884-891. (Pubitemid 39435003)
41. Wang Y, Gu Y, Zhang Y, Lewis DF. Evidence of endothelial dysfunction in preeclampsia: decreased endothelial nitric oxide synthase expression is associated with increased cell permeability in endothelial cells from preeclampsia. Am J Obstet Gynecol. 2004;190(3):817-824. (Pubitemid 38406799)
42. Takacs P, Green KL, Nikaeo A, Kauma SW. Increased vascular endothelial cell production of interleukin-6 in severe preeclampsia. Am J Obstet Gynecol. 2003;188(3):740-744. (Pubitemid 36332443)
43. Greer IA, Lyall F, Perera T, Boswell F, Macara LM. Increased concentrations of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: a mechanism for endothelial dysfunction? Obstet Gynecol. 1994;84(6):937-940. (Pubitemid 24360251)
44. Shibuya M. Vascular endothelial growth factor receptor-1 (VEGFR-1/Flt-1): a dual regulator for angiogenesis. Angiogenesis. 2006;9(4):225-230.
45. Zhou Y, McMaster M, Woo K, et al. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol. 2002;160(4):1405-1423. (Pubitemid 34411644)
46. Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350(7):672-683. (Pubitemid 38364626)
47. McKeeman GC, Ardill JE, Caldwell CM, Hunter AJ, McClure N. Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop. Am J Obstet Gynecol. 2004;191(4):1240-1246. (Pubitemid 39421577)
48. Wathen KA, Tuutti E, Stenman UH, et al. Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation. J Clin Endocrinol Metab. 2006;91(1):180-184. (Pubitemid 43069135)
49. Sandrim VC, Palei ACT, Metzger IF, Gomes VA, Cavalli RC, Tanus-Santos JE. Nitric oxide formation is inversely related to serum levels of antiangiogenic factors soluble FMS-like tyrosine kinase-1 and soluble endogline in preeclampsia. Hypertens. 2008;52(2):402-407.
50. Hewett PW, Murray JC, Price EA, Watts ME, Woodcock M. Isolation and characterization of microvessel endothelial cells from human mammary adipose tissue. In Vitro Cell Dev Biol. 1993;29(4):325-331. (Pubitemid 23252356)
51. Nilius B, Schwarz G, Oike M, Droogmans G. Histamineactivated, non-selective cation currents and Ca21 transients in endothelial cells from human umbilical vein. Pflügers Arch. 1993;424(3-4):285-293. (Pubitemid 23227683)